About this Research Topic
After the COVID-19 pandemic, a number of infectious diseases or infection-related diseases have emerged or re-emerged in children. These diseases have occurred in a larger number of cases or manifested differently or more severely than prior to the COVID-19 era, resulting in increased pressure on patients and those in healthcare settings. There is thus an unmet need to investigate the increased burden of these diseases in children.
This topic will call for original studies, case reports, or expert reviews/opinions on the above, with the aim of:
1. Addressing the epidemiologic, clinical, and molecular characteristics of infectious or infection-related diseases in children that are emerging or have re-emerged after the COVID-19 pandemic.
2. Presenting the foundation to generate the hypotheses or to elucidate the biological mechanism for the emergence or re-emergence of these diseases.
3. Addressing clinical management and the response of healthcare settings or public health authorities to the emergence or re-emergence of these diseases.
The emerging or re-emerging infectious diseases after the COVID-19 pandemic that will be addressed may include diseases caused by bacteria, viruses, fungi, parasites, or vectors, or diseases related to infection such as multisystem inflammatory syndrome in children (MIS-C), postinfectious bronchiolitis obliterans (PIBO), and so on.
We therefore welcome submissions of original research, case reports, or expert reviews and opinion articles on the following themes, in relation to the above diseases:
• Epidemiologic characteristics
• Clinical characteristics
• Molecular characteristics
• Potential mechanisms
• Clinical management
• Diagnostics in children
• Vaccination in children
• Response of healthcare settings or public health authorities
This topic will call for original studies, case reports, or expert reviews/opinions on the above, with the aim of:
1. Addressing the epidemiologic, clinical, and molecular characteristics of infectious or infection-related diseases in children that are emerging or have re-emerged after the COVID-19 pandemic.
2. Presenting the foundation to generate the hypotheses or to elucidate the biological mechanism for the emergence or re-emergence of these diseases.
3. Addressing clinical management and the response of healthcare settings or public health authorities to the emergence or re-emergence of these diseases.
The emerging or re-emerging infectious diseases after the COVID-19 pandemic that will be addressed may include diseases caused by bacteria, viruses, fungi, parasites, or vectors, or diseases related to infection such as multisystem inflammatory syndrome in children (MIS-C), postinfectious bronchiolitis obliterans (PIBO), and so on.
We therefore welcome submissions of original research, case reports, or expert reviews and opinion articles on the following themes, in relation to the above diseases:
• Epidemiologic characteristics
• Clinical characteristics
• Molecular characteristics
• Potential mechanisms
• Clinical management
• Diagnostics in children
• Vaccination in children
• Response of healthcare settings or public health authorities
Keywords: Infectious diseases, children, emerging, re-emerging, COVID-19
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
